What happened
GeneOne Life Science updated the terms of convertible bonds to raise US$3.38M, about 10.5% of its market value.
For context, this raise equals about 10.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$3.38M |
| vs. market value | 10.5% |
| Filed | 2026-04-02, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260402003707 → open original filing |
Source: DART. Information only, not investment advice.